| | |||||||
| disease | |||||||
| 新闻 | |||||||
| ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path ... ... disease (N=80) demonstrate approximately 96% bladder cancer-specific survival and greater than 80% bladder preservation at three years, with ...
| |||||||
| Antimicrobial Antibody Response May Predict Crohn Disease Risk in First-Degree Relatives HealthDay News — For healthy first-degree relatives (FDRs) of patients with Crohn disease (CD), increased antibody response toward Lachnospiraceae ...
| |||||||
| First Treatment for Menkes Disease: FDA Approves Copper Histidinate - Neurology Advisor The Food and Drug Administration (FDA) has approved Zycubo® (copper histidinate) for the treatment of Menkes disease in pediatric patients.
| |||||||
Investigating Treatments for Peripheral Artery Disease - News Center A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, according to results ...
| |||||||
| |||||||
| COVID-19 Vaccine Reduces Risk for Severe Maternal Disease and Preterm Birth Immunization against SARS-CoV-2 prior to diagnosis was linked to reduced maternal disease severity and lower rates of preterm birth.
| |||||||
| Plasma P-Tau217 Accurately Detects Preclinical Alzheimer Disease Pathology Research and therapeutic efforts in Alzheimer Disease (AD) are increasingly focused on identifying individuals in the preclinical stage, when ...
| |||||||
| New grants kickstart major effort on women's cardiovascular health - Novo Nordisk Fonden Cardiovascular disease is the leading cause of death among women worldwide, yet for decades, research and clinical practice have focused primarily on ...
| |||||||
| 查看更多结果 | 修改此快讯 | |||||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment